Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress Pharmaceutical Investing
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid Injectables with JUVÉDERM® at AMWC Monaco Pharmaceutical Investing
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026 Pharmaceutical Investing
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights Life Science Investing
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts Pharmaceutical Investing
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration Life Science Investing
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting Life Science Investing
